iShares U.S. Pharmaceuticals ETF (IHE) Holdings → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free IHE Stock Alerts $65.68 +0.35 (+0.54%) (As of 05/8/2024 ET) Add Compare Share Share HoldingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings Top 38 IHE HoldingsRankCompanyCurrent PriceWeightShares Held1LLYEli Lilly and Company$775.00-0.4%22.75%204,2652JNJJohnson & Johnson$148.95+0.2%22.67%999,6203MRKMerck & Co., Inc.$129.48-0.7%4.97%257,4214PFEPfizer$28.28+1.8%4.67%1,171,6035RPRXRoyalty Pharma$27.99-1.0%4.63%1,071,1466VTRSViatris$11.81+0.8%4.50%2,611,138 Get the Latest News and Ratings for IHE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 7BMYBristol-Myers Squibb$43.67-0.8%4.48%596,7768CTLTCatalent$56.18-0.6%4.30%505,7579ZTSZoetis$164.92-2.1%3.90%173,57310ITCIIntra-Cellular Therapies$67.00-5.9%2.98%268,25411JAZZJazz Pharmaceuticals$110.70-0.5%2.97%176,17212ELANElanco Animal Health$16.88+24.9%2.74%1,378,99213OGNOrganon & Co.$20.37-0.1%1.95%715,26014PRGOPerrigo$31.11+3.2%1.79%379,18515PBHPrestige Consumer Healthcare$69.83-0.2%1.48%138,93216AXSMAxsome Therapeutics$75.68-1.6%1.13%108,58017ARVNArvinas$32.37-5.7%1.01%190,28118CORTCorcept Therapeutics$25.40+3.8%0.89%253,83619SUPNSupernus Pharmaceuticals$31.30+0.5%0.69%152,87920AMPHAmphastar Pharmaceuticals$42.21-1.3%0.64%104,56521PCRXPacira BioSciences$29.65+11.8%0.52%129,94722LGNDLigand Pharmaceuticals$80.36+9.8%0.51%45,86423COLLCollegium Pharmaceutical$38.06+2.0%0.49%91,25524ANIPANI Pharmaceuticals$65.62-1.6%0.42%42,22025EWTXEdgewise Therapeutics$20.89-1.6%0.42%178,70226HRMYHarmony Biosciences$31.70+1.1%0.41%91,64427TARSTarsus Pharmaceuticals$37.35-1.8%0.37%74,16928INVAInnoviva$15.56+0.2%0.36%157,94929SAVACassava Sciences$21.57-1.2%0.33%111,19930PLRXPliant Therapeutics$13.41-2.8%0.28%145,95031AMRXAmneal Pharmaceuticals$6.59+1.2%0.26%317,63432RVNCRevance Therapeutics$4.27-2.5%0.14%245,97033TBPHTheravance Biopharma$9.49-0.5%0.14%96,21034BLK CSH FND TREASURY SL AGENCYN/A0.11%696,89735USDProShares Ultra Semiconductors$93.26+0.1%0.04%238,85436AMLXAmylyx Pharmaceuticals$1.93-2.0%0.03%112,28637CASH COLLATERAL USD SGAFTN/A0.01%34,00038E-MINI HEALTH CARE SECTOR JUN 24N/A0.00%6 Geographic ExposureUnited States95.1%Ireland4.8%Cayman Islands0.1%Currency ExposureUSD100.0%Sector ExposureHealth Care91.1%Energy0.4%Industry ExposureBiotechnology74.8%Pharmaceuticals7.5%Health Care Equipment & Supplies4.2%Renewable Energy0.4%SubIndustry ExposureBiotechnology72.0%Pharmaceuticals9.1%Health Care Equipment4.2%Renewable Energy Equipment0.4%Coupon Exposure0-299.8%4-60.2% Related Companies and Tools Related Companies: iShares U.S. Healthcare Providers ETF Portfolio VanEck Pharmaceutical ETF Portfolio VanEck Biotech ETF Portfolio Invesco S&P 500 Equal Weight Health Care ETF Portfolio Invesco S&P 500 Equal Weight Health Care ETF Portfolio Invesco Pharmaceuticals ETF Portfolio SPDR S&P Health Care Equipment ETF Portfolio Invesco Biotechnology & Genome ETF Portfolio Invesco S&P SmallCap Health Care ETF Portfolio First Trust NYSE Arca Biotechnology Index Fund Portfolio This page (NYSEARCA:IHE) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressObama’s Forever Term [exposed]Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
